898 related articles for article (PubMed ID: 23777885)
21. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
[TBL] [Abstract][Full Text] [Related]
22. Ligand-based targeted therapy for cancer tissue.
Das M; Mohanty C; Sahoo SK
Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
[TBL] [Abstract][Full Text] [Related]
23. The therapeutic potential of cell-internalizing aptamers.
Zhou J; Rossi JJ
Curr Top Med Chem; 2009; 9(12):1144-57. PubMed ID: 19860714
[TBL] [Abstract][Full Text] [Related]
24. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
[TBL] [Abstract][Full Text] [Related]
25. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges.
He F; Wen N; Xiao D; Yan J; Xiong H; Cai S; Liu Z; Liu Y
Curr Med Chem; 2020; 27(13):2189-2219. PubMed ID: 30295183
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA.
Wilner SE; Levy M
Methods Mol Biol; 2016; 1380():211-24. PubMed ID: 26552829
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA.
Zhu Q; Shibata T; Kabashima T; Kai M
Eur J Med Chem; 2012 Oct; 56():396-9. PubMed ID: 22907035
[TBL] [Abstract][Full Text] [Related]
28. Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer.
de Almeida CEB; Alves LN; Rocha HF; Cabral-Neto JB; Missailidis S
Int J Pharm; 2017 Jun; 525(2):334-342. PubMed ID: 28373101
[TBL] [Abstract][Full Text] [Related]
29. Aptamers used for biosensors and targeted therapy.
Ning Y; Hu J; Lu F
Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
[TBL] [Abstract][Full Text] [Related]
30. Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.
Benedetto G; Vestal CG; Richardson C
Target Oncol; 2015 Dec; 10(4):467-85. PubMed ID: 25989948
[TBL] [Abstract][Full Text] [Related]
31. Chimeric aptamers in cancer cell-targeted drug delivery.
Kanwar JR; Roy K; Kanwar RK
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
[TBL] [Abstract][Full Text] [Related]
32. Aptamer-functionalized hydrogel as effective anti-cancer drugs delivery agents.
Wang Z; Xia J; Cai F; Zhang F; Yang M; Bi S; Gui R; Li Y; Xia Y
Colloids Surf B Biointerfaces; 2015 Oct; 134():40-6. PubMed ID: 26142627
[TBL] [Abstract][Full Text] [Related]
33. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
Guan B; Zhang X
Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
[TBL] [Abstract][Full Text] [Related]
34. An exploration of aptamer internalization mechanisms and their applications in drug delivery.
Wan LY; Yuan WF; Ai WB; Ai YW; Wang JJ; Chu LY; Zhang YQ; Wu JF
Expert Opin Drug Deliv; 2019 Mar; 16(3):207-218. PubMed ID: 30691313
[TBL] [Abstract][Full Text] [Related]
35. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
Zhong Y; Zhao J; Li J; Liao X; Chen F
Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
[TBL] [Abstract][Full Text] [Related]
36. Nucleic acid aptamers targeting cell-surface proteins.
Dua P; Kim S; Lee DK
Methods; 2011 Jun; 54(2):215-25. PubMed ID: 21300154
[TBL] [Abstract][Full Text] [Related]
37. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
38. Towards targeted cancer therapy: Aptamer or oncolytic virus?
Tan KX; Danquah MK; Sidhu A; Ongkudon CM; Lau SY
Eur J Pharm Sci; 2017 Jan; 96():8-19. PubMed ID: 27593990
[TBL] [Abstract][Full Text] [Related]
39. A polyvalent aptamer system for targeted drug delivery.
Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
[TBL] [Abstract][Full Text] [Related]
40. Aptamer as a targeted approach towards treatment of breast cancer.
Bisht A; Bhowmik S; Patel P; Gupta GD; Kurmi BD
J Drug Target; 2024 Jun; 32(5):510-528. PubMed ID: 38512151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
